Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, Minnesota 55905


Purpose:

Patients receive budesonide or placebo for the treatment of active lymphocytic colitis. This study includes stool collections, blood draws, weekly questionnaires and a sigmoidoscopy.


Study summary:

Patients have stool specimen and blood drawn at the start of the study. Patient takes ether Budesonide or placebo for 8 weeks. At the end of treatment, patient has stool collection and sigmoidoscopy.


Criteria:

Inclusion Criteria: - Diarrhea, defined as greater than 4 bowel movements per day and greater than "mild"; currently on no treatment or active despite treatment. - Lymphocytic colitis confirmed histologically within one year of enrollment


NCT ID:

NCT00217022


Primary Contact:

Principal Investigator
Darrell S. Pardi, M.D.
Mayo Clinic


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota 55905
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.